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Leaf extracts of Cassia roxburghii DC., prepared in petroleum ether,
chloroform, ethyl acetate, butanol, and methanol/water (70:30,
v/v), were evaluated as antioxidant, pro-oxidant, anti-infectious,
and cytotoxic agents. The major metabolite of each extract was
identified by chromatographic and spectroscopic means. The redox
properties were assessed with a battery of assays, which revealed
that the ethyl acetate extract demonstrated an interesting scav-
enging activity of DPPH and superoxide radicals and an ascorbic
acid-like pro-oxidant activity. All the tested extracts showed moder-
ate antiplasmodial activity against a chloroquine-resistant strain
of Plasmodium falciparum, by possible disruption of parasite fine
redox balance. Cytotoxicity was evaluated against a human breast
cancer cell line. The antimicrobial activities of the extracts were
estimated against representative bacterial strains (Staphylococcus
aureus, Enterococcus hirae, Pseudomonas aeruginosa, Escherichia
coli) and fungal species (Candida albicans, Aspergillus niger).
The ethylacetate extract possessed the highest redox properties and
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exhibited the highest antiplasmodial activity; there was no correla-
tion between antibacterial activity and the redox properties of the
extracts.
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INTRODUCTION
Plants belonging to Cassia species are extensively used in traditional
medicine in various parts of the world against a wide range of ailments (13).
Various species of Cassia are reported to have antiviral (1), anti-inflammatory
(6), larvicidal (7), antiprotozoal (22), antimalarial (14, 28), hepatoprotective
(19), and anticancer (24) properties.
Cassia roxburghii DC. (Caesalpiniaceae), also known as C. marginata
Roxb. (26), is a small deciduous tree native to Sri Lanka, southern India,
and Egypt, where it is used in folk medicine to treat various liver disorders.
The in vivo hepatoprotective effect of Cassia roxburghii seed have been
reported (2). Skin diseases such as ringworm infections and the wound heal-
ing potential of Cassia roxburghii seed and leaf extracts have been reported
(21). It has also been used as a cathartic agent (11). Phytochemical stud-
ies have demonstrated the presence of alkaloids, sterols, anthraquinones,
glycosides, tannins, and flavonoids in C. marginata (5, 13, 20). In spite of
this phytochemical richness, little is known about the redox capacity and
bioactive properties of C. marginata.
The aim of this study was to evaluate the redox properties of Cassia
roxburghii leaves. The in vitro anti-infectious activity of leaf extracts was
evaluated against representative Gram-positive and Gram-negative bacterial
strains (S. aureus CIP 4.83, E. hirae CIP 5855, P. aeruginosa CIP 82118, E. coli
CIP 53126), fungal species (C. albicans IP 48.72, A. niger IP 1431.83), and a
protozoan (Plasmodium falciparum) in relation to the redox capacity of the
extracts. Cytotoxicity against a human breast cancer cell line (MCF-7) is also
reported.
MATERIALS AND METHODS
Plant Material
Cassia marginata Roxb (C. roxburghii DC.) leaves were collected in
December 2006 from the Orman Botanical Garden, Giza, Egypt. Plant sam-
ples were authenticated by the taxonomist of the Orman Botanical Garden.
A voucher specimen No. C-5-63 was kept in the Herbarium of Orman
Garden.
Extraction and Isolation
The shade dried powdered leaves of C. roxburghii (250 g) were defatted
with petroleum ether. The crude petroleum ether extract (I), 17 g, was chro-
matographed on a flash column of silica gel G, eluted with petroleum ether
(60–80) with gradient increase of polarity with ethyl acetate (0.5, 1, 2, 3,
and 5%), allowing the isolation of emodin from fraction eluted with 2%
ethyl acetate. The defatted powder was then extracted with methanol/water
(70:30, v/v) and evaporated under vacuum yielding the total defatted extract
(V), 60 g, which was further fractionated with chloroform (II), 6 g; ethyl
acetate (III), 15 g; and butanol (IV), 12 g. Part of the total extract (V) was
kept for biological study. The chloroform fraction (II) was applied to a silica
gel column, and eluted with n-hexane/ethyl acetate with increasing polarity,
resulting in the isolation of aloe-emodin. The ethyl acetate fraction (III) was
subjected to reversed phase liquid chromatography on Sephadex LH20 to
give quercitrin. The butanol fraction (IV) was fractionated on polyamide
to yield three fractions that were purified by paper chromatography (15%
AcOH), and then on a Sephadex LH20 sub-column to obtain emodin glu-
coside and aloe-emodin glucoside. Pure compounds were chromatographed
with two-dimensional TLC on cellulose using butanol:acetic acid:water, 4:1:5
(BAW) and 15% acetic acid as solvent systems.
Chemicals
Dimethyformamide (DMF), dimethylsulfoxide (DMSO), acetonitrile (ACN),
ethanol, linoleic acid, xanthine, xanthine oxidase, superoxide dismu-
tase, ascorbic acid, α-tocopherol (vitamin E), Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), Tween 20, β-carotene, H2O2, FeCl3,
diethylenetriamine pentacetate (DTPA), 5,5-dimethyl-1-pyrroline N -oxide
(DMPO), and 2,2-diphenyl-1-picrylhydrazyl (DPPH•) were purchased from
Sigma (Sigma-Aldrich, France). Polyamide 0.05–0.16 mm (Roth) was used
for column chromatography. TLC analysis was carried out using cellulose
and silica gel 60 F254 plates (Merck).
Instruments
UV absorption spectra were recorded on UV-visible double beam UWD-
3500 spectrophotometer (Labomed, Inc.). Mass spectrometry analyses were
performed on a Finnigan MAT 112 electron impact ionization at 70 eV. 1H and
13C NMR spectra were done on a Varian Mercury VX 300 NMR spectrometer at
300 MHz and 75 MHz, respectively, using DMSO-d6 or CDCl3 as solvents. The
chemical shifts were reported in ppm values using tetramethylsilane (TMS)
as the internal standard. Chromatograms were visualized under UV light at λ
366 nm before and after spraying with ammonia (Naturstoff reagent A, Roth)
reagent. Electron paramagnetic resonance (EPR) spectra were obtained at
X-band on a Bruker EMX-8/2.7 spectrometer (Bruker, Wissembourg, France)
(9.86 GHz) equipped with a high-sensitivity cavity (4119/HS 0205) and a
gaussmeter (Bruker). A flat quartz cell FZK160- 5 × 0.3 mm (Magnettech,
Berlin, Germany) was used for analysis. EPR data processing and spectrum
computer simulation were performed using WINEPR and SIMFONIA software
(Bruker). Typical scanning parameters were: scan rate, 1.2 G/s; scan number,
1; modulation amplitude, 1 G; modulation frequency, 100 kHz; microwave
power, 20 mW; sweep width, 100 G; sweep time, 83.88 s; time constant,
40.96 ms; magnetic field, 3450–3580 G.
Major Chemical Components in Tested Fractions
Emodin was obtained from the petroleum ether fraction (I). The structural
identification was carried out by UV, MS, and NMR spectroscopies. The
results match with the previously reported data of emodin (8).
Aloe-emodin was obtained from the chloroform extract (II). The
anthraquinone was isolated as yellowish needles from methanol, mp
220–222◦C. EIMS, m/z: 270 [M+]; 1H NMR (CDCl3,300 MHz): δ (ppm) 12.04
(s, 1H, OH-8), 11.97 (s, 1H, OH-1), 7.76 (dd, J = 0.76 and 7.52Hz,1H, H-5),
7.60 (d, J = 8.1 Hz, 1H, H-6), 7.59 (d, J = 0.4 Hz, 1H, H-4), 7.23 (dd, J =
0.74 and 8.4 Hz, 1H, H-7), 7.04 (d, J = 0.4 Hz, 1H, H-2), 4.50 (s, 2H, H-3).
Quercitrin (quercetin 3-O-α-rhamnoside) was obtained from the ethyl
acetate extract (III). The structural identification of quercetin-3-O-α-
rhamnopyranoside was carried out by UV, MS, and NMR spectroscopy. UV
λmax (MeOH): 265, 298sh, 351 nm; (+NaOMe): 271, 326sh, 398 nm; (+AlCl3):
275, 304, 330, 422 nm; (+AlCl3/+HCl): 269, 300sh, 353, 398 nm; (+NaOAc):
269, 317, 362 nm; (+NaOAc /H3BO3): 259, 299, 378 nm. EIMS, m/z: 448 [M
+], 302 [M+ - rhamnose unit]. 1H NMR (DMSO-d6, 300 MHz): δ (ppm) 12.60
(s, 1H, 5-OH), 7.29 (d,J = 1.5 Hz, 1H, H-2′), 7.24 (d, J = 8.4 Hz, 1H, H-6′),
6.85 (d, J = 8.4 Hz, 1H, H-5′), 6.36 (br.s,1H, H-8), 6.19 (br.s, 1H, H-6), 5.25
(s, 1H, H-1′′), 0.81 (d, J = 6.0 Hz, 3H,–CH3). 13C NMR (DMSO-d6, 75 MHz):
δ (ppm) 156.9 (C-2), 134.6 (C-3), 178.2 (C-4), 161.8 (C-5), 99.3 (C-6), 165.1
(C-7), 94.1 (C-8), 157.7 (C-9), 104.4 (C-10), 121.6 (C-1′), 115.9 (C-2′), 145.7
(C-3′), 149.0 (C-4′), 116.1 (C-5′), 121.2 (C-6′), 102.3 (C-1′′), 70.8 (C-2′′), 71.0
(C-3′′), 71.7 (C-4′′),70.5 (C-5′′), 18.0 (C-6′′). The MS, 1H NMR, and 13C NMR
data are in agreement with those of quercetin-3-O-α- rhamnpyranoside (9).
Two pure anthraquinone glycosides from the butanol extract (IV) were
chromatographed with two-dimensional TLC on cellulose (BAW/15% acetic
acid as solvent systems). The two anthraquinone glycosides had Rf values
of 0.34 and 0.43 in BAW and 0.70 and 0.62 in 15% acetic acid, respec-
tively. The two compounds were identified by chemical tests (positive
Borntrager’s test and positive Molish’s test), acid hydrolysis with HCl (2 N),
and co-chromatography with authentic standards (BAW 4:1:5 as the sol-
vent system). This enabled glucose to be identified as the sugar moiety
and emodin and aloe-emodin as the aglycone. ESI mass [M+2H]+ 596. The
two compounds were identified as emodin diglucoside and aloe-emodin
diglucoside.
Redox Properties
SIMPLE PRO-OXIDANT ASSAY
Extract (100 mg/L) and DMPO (50 mM) were diluted in DMSO/HEPES
buffer, pH = 7.4, (10/90) solution. EPR spectra were recorded (accumu-
lation of 10 scans) every 15 minutes during 1 h. Ascorbic acid (100 μM)
and artemisinin (100 μM) were used as positive and negative controls,
respectively.
FE3+/H2O2 PRO-OXIDANT ASSAY
HEPES buffered solutions (50 mM, pH = 7.4) containing 250 μM FeCl3, 250
μM hydrogen peroxide, 100 mg/L of extract in DMF (100 μL), and 50 mM
DMPO were incubated for 2 min at room temperature prior to EPR measure-
ments (accumulation of 10 scans). Ascorbic acid (100 μM) and artemisinin
(100 μM) were used as positive and negative controls respectively.
FE2+ PRO-OXIDANT ASSAY
Solutions containing 8.3 mM Fe(NH4)2(SO4)2, 2.2 mg/mL of extract in DMF,
and 167 mM DMPO were incubated for 10 min at room temperature prior
to EPR spectra recording (accumulation of 10 scans). As a positive control,
artemisinin (6.67 mM) replaced the extract (15).
DPPH Assay
The antioxidant activity was evaluated using the stable 2,2-diphenyl-2-
picrylhydrazyl nitrogen-centered free radical (DPPH•). DPPH• in ethanol (300
μM, 100 μL) was added to 200 μL of the test compounds at different concen-
trations in the appropriate solvent (MeOH, EtOH, MeOH/H2O 2:1, v/v). Each
mixture was then mixed thoroughly and the absorbance was recorded every
5 min for 30 min, using a microplate reader (UVMax, Molecular Devices).
The decrease in DPPH• absorbance (at λ 530 nm) was monitored. DPPH•
solution (100 μL) in the respective solvent (200 μL) served as the blank.
All tests were performed in triplicate. The radical scavenging activity of the
samples (antioxidant activity) was expressed in terms of IC50 (concentration
in mg/L required for a 50% decrease in DPPH• absorbance).
A plot of absorbance vs. concentration was made to establish the stan-
dard curve and to calculate the IC50. Ascorbic acid and Trolox (water soluble
form of vitamin E) were used as positive controls and vitamin E acetate was
used as the negative control.
Beta-Carotene Bleaching Assay
The antioxidant activity of extracts was determined according to the β-
carotene bleaching method (12, 16, 23) with the following modifications:
A solution of β-carotene was prepared by dissolving 2 mg of β-carotene
in 1 mL of chloroform. 500 μL of this solution was then transferred into a
round-bottom rotary flask containing 15 mg of linoleic acid and 200 mg of
Tween 20. After removing the chloroform under a nitrogen stream, 50 mL of
aerated distilled water was added to the flask with manual shaking. Aliquots
of 5 mL of this prepared emulsion were transferred into tubes containing
200 μL of extracts or α tocopherol (50 mg/L), which was used as positive
control. The blank consisted of 0.2 mL of the respective solvent without the
extract. Zero time absorbance was recorded at λ 470 nm as quickly as pos-
sible. The samples were then subjected to thermal autoxidation at 50 ◦C in
a temperature-controlled eight-cell holder. Subsequent absorbance readings
were recorded at regular time intervals until the color of the β-carotene in
the control sample had disappeared (25 min). The extent of inhibition of β-
carotene bleaching is related to the concentration of antioxidant compounds.
All samples were assessed in triplicate. Antioxidant activity (AA) was calcu-
lated as percentage inhibition of β-carotene bleaching relative to the blank
using the following equation:
AA = [1 − (Ai − At)/(A′i − A′t)] × 100
where Ai is the measured absorbance value of the sample at zero time; At
is the measured absorbance value of the sample after incubation (25 min) at
50 ◦C; A′i is the measured absorbance value of the blank at zero time, and
A′t is the measured absorbance value of the blank after incubation (25 min)
at 50 ◦C.
Superoxide Assay
The superoxide radical was generated by reaction of the xanthine–xanthine
oxidase system. The extract sample was dissolved in dimethyl sulfoxide
(DMSO). 0.5 mM xanthine (80 μL), DMSO, or extract solution (final volume
32 μL), 1 M DMPO (32 μL), appropriate volume of HEPES buffer containing
0.1 mM DTPA, and xanthine oxidase (20 units/mL) (10 μL) were mixed in a
test tube to give a total volume of 400 μL. The mixture was quickly trans-
ferred to a flat quartz cell. The EPR spectra of the DMPO-OOH spin adducts
were recorded 90 s after xanthine oxidase addition. The radical scaveng-
ing activity of the samples was expressed in terms of percent inhibition of
DMPO-OOH spin adduct according to the following formula:
% Inhibition = [(Iblank − Itest)/Iblank] × 100)
where Iblank is the intensity of the first peak of the blank spectrum, Itest is
the intensity of the first peak of the test sample spectrum. Ascorbic acid was
used as positive control.
Antimicrobial Assays
The extracts were dissolved in water/DMSO to obtain an initial concentration
of 1000 μg/mL. The resulting solutions were then diluted in microtiter plates
in culture medium: trypcase soja (Biomérieux, Craponne, France) for bacte-
ria and Sabouraud (Biomérieux) for fungi and yeast. Gram-positive strains
S. aureus CIP 4.83 and E. hirae CIP 58.55 and Gram-negative strains, P.
aeruginosa CIP 82118 and E. coli CIP 53126 were used for the antimicrobial
assays. For the antifungal assay cultures,a yeast, C. albicans IP 48.72, and
mold, A. niger IP 1431.83, were employed. Strains were obtained from
the collection of the Pasteur Institute (Paris, France). Microbial suspen-
sions were prepared in sterile distilled water to obtain final inoculums
of 106 cells/mL and 105 spores/mL for bacteria and fungi, respectively.
Minimal inhibitory concentrations (MICs) and minimal germicidal concen-
trations (MBC or MFC) were determined after incubation of the bacterial
strains at 37 ◦C for 24 h and the fungal strains at 30 or 22.5 ◦C for 24 h
(36 h for A. niger) in the presence of serial dilutions of the test compounds.
The MIC was defined as the concentration of compound at which no macro-
scopic sign of cellular growth was detected in comparison to the control
without antimicrobial compound. The MBC/MFC were determined by sub-
cultivating on corresponding agar plates after incubation of the bacterial
strains at 37 ◦C for 24 h and fungal strains at 30 or 22.5 ◦C for 48 h. MBC/MFC
was defined as the concentration of compound at which no macroscopic
sign of cellular growth was detected in comparison to the control without
antimicrobial compound upon subculturing. All the experiments were car-
ried out in duplicate at each concentration. In order to ensure that DMSO
per se did not interfere with the antimicrobial activity evaluation of the prod-
ucts under assay, a control test was also performed containing inoculated
broth supplemented with only DMSO at the same dilutions used in our
experiments.
Antiplasmodial Assay
Antiplasmodial activity was tested according to the protocol previously
reported (18). RPMI 1640 medium [BioWhittaker, Cambrex (cat no. BE12-
702F), Belgium] containing L-glutamine (BioWhittaker, cat no. BE17-605E),
25 mM HEPES (BioWhittaker, cat no. 17-737F), and 10% human serum
(Etablissement Français du Sang, EFS, Toulouse, France), was used to cul-
tivate P. falciparum (P.f.). Human red blood cells (RBCs; group O±) were
obtained from EFS. They were extensively washed with RPMI medium to
remove plasma and leucocytes. Leucocyte-free erythrocytes were stored at
50% hematocrit for a maximum period of 21 days. P.f. asexual blood stage
parasites were propagated by incubation at 37 ◦C in P.f. culture media
at 3–5% hematocrit in a controlled atmosphere (5% CO2, 100% relative
humidity). Parasitized RBCs were maintained in 25 cm2 culture flasks (TPP,
Switzerland, ref 90025). The reference drugs chloroquine (CQ) and arte-
sunate were obtained from Sigma (ref C6628) and Cambrex, respectively.
CQ was dissolved in culture medium and artesunate in ethanol (stock solu-
tions: 10 mg/mL) and stored at –20 ◦C prior to testing. For extract assays,
serial extract dilutions were made in P.f. culture media and added to 96-well
(TPP) culture plates. All samples were tested in triplicate. Plasmodium-
infected RBCs were distributed at 2% parasitaemia (2% hematocrit) in 96-well
microtiter plates with different drug concentrations and incubated for 48 h at
37 ◦C and 5% of CO2. [3H]-Hypoxanthine (Perkin-Elmer) was added 24 h
after the beginning of the incubation. At the end of incubation (48 h),
microtiter plates were frozen and thawed, and each well was harvested onto
a glass-fiber filter paper. The quantity of incorporated [3H]-hypoxanthine was
determined with a beta-counter (1450-Microbeta Trilux, Wallac-PerkinElmer).
Growth-inhibition percentages were plotted as a semi-logarithmic function
of drug concentration. The IC50 values were determined by linear regression
analysis on the linear segments of the curves. Assays were repeated three
times. Controls were carried out to assess the background (negative control)
and parasite growth (positive control).
Cytotoxicity Assay
The cytotoxicity was tested according to the protocol previously reported
(18). Cytotoxicity was estimated on human breast cancer cells (MCF7) cul-
tured in the same conditions as those used for P. falciparum, except
that 10% human serum was replaced by 10% fetal calf serum (Cambrex).
After trypsinization, cells were distributed in 96-well plates at 2 × 104
cells/well in 100 μL of culture medium added to 100 μL of the same
medium containing the test samples at various concentrations (the final
concentrations in the wells were 1, 10, and 100 μg/mL). Cell growth was
estimated by a colorimetric assay based on sodium 2,3-bis(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT; Sigma,
Saint Quentin Fallavier, France) reduction. After 48 h of contact between
cells and test compounds the culture medium was replaced by 50 μl of a
XTT in water solution (0.5 mg/mL), and cells were incubated for 180 min.
XTT was converted into a formazan product, detected at λ 450 nm. IC50 val-
ues were determined graphically from dose–response curves (the positive
control being doxorubicin; Sigma). Experiments were performed twice in
triplicate.
RESULTS
The main flavonoid or anthranoids present in each extract after purifi-
cation and identification were emodin, aloe-emodin, and quercetin-3-O-α-
rhamnpyranoside in petroleum ether (I), chloroform (II), and ethyl acetate
(III) extracts, respectively, and emodin diglucoside and aloemodin diglu-
coside in butanol extract (IV). The four extracts, along with the defatted
methanol/water (total extract) (V) of C. roxburghii DC. leaf, were evaluated
for their redox molecular pool with different pro-oxidant and antioxidant
assays.
To explore whether the extracts possess artemisinin-like and/or an
ascorbic acid–like pro-oxidant activities or not, the pro-oxidant capacity of
Cassia roxburghii DC. leaf extracts was evaluated using EPR spectroscopy
according to three different assays. The results are summarized in Table 1.
The ethyl acetate extract (III) demonstrated an ascorbic acid-like pro-oxidant
activity.
The antioxidant properties were assessed using DPPH, β-carotene-
bleaching, and superoxide assays (Table 2). The antioxidant activity of the
extracts was expressed as IC50 and percentage inhibition. The ethyl acetate
extract (III) demonstrated the highest antioxidant properties in the DPPH
and superoxide radical scavenging assays.
The antimicrobial potential of Cassia roxburghii DC. leaf extracts was
evaluated on selected bacterial and fungal strains. Table 3 demonstrates the
antimicrobial properties of the extracts. The majority of the extracts exhibited
antibacterial activity against Gram-positive bacteria, with MIC values around
125 μg/mL. Interestingly, the Gram-negative strain P. aeruginosa and the
yeast C. albicans were more susceptible to the majority of the extracts, with
MIC values of 62.5 μg/mL.
Cassia roxburghii DC. leaf extracts were assessed for their
antiplasmodial activity against a chloroquine-resistant strain of P. falciparum.
The cytotoxicity of the extracts was also evaluated on a human breast cancer
cell line (MCF-7). Selectivity index was calculated as the ratio of CC50 value
in MCF-7 cells to IC50 value in the CQ-resistant P.f . strain FcB1. The results
are shown in Table 4.
TABLE 1 Pro-oxidant capacity of Cassia roxburghii DC leaf extracts
Extract
Simple pro-oxidant
assay
Fe3+/H2O2 pro-oxidant
assay I1 ± SD (RSD %)
Fe2+ pro-oxidant assay
I1 ± SD (RSD %)
I Inactive I1 = 7317 ± 327 (4 %) Inactive
quadrupletc
II Inactive I1 = 6767 ± 510 (8 %) I1 = 517 ± 74 (14 %)
quadrupletc sextupletd
III Inactive I1 = 9967 ± 332 (3 %) I1 = 1857 ± 23 (1 %)
quadrupletc sextupletd
IV Inactive I1 = 8867 ± 527 (6 %) I1 = 1648 ± 139 (8 %)
quadrupletc sextupletd
V Inactive I1 = 8667 ± 330 (4 %) I1 = 2057 ± 29 (1 %)
quadrupletc sextupletd
artemisinin Inactive Inactive I1 = 6133 ± 464 (8 %)
sextupletd
ascorbic acid I1a = 1534 I1 = 13137 I1 = 783 ± 73 (9 %)
doubletb (ascorbyl
radical)
doubletb (ascorbyl
radical)
doubletb (ascorbyl
radical)
aI1: intensity of the first peak of the EPR signal.
baH = 1.8 Gauss; g = 2.0051.
caN = 14.7 Gauss; aH = 14.5 Gauss; g = 2.0058.
daN = 15.2 Gauss; aH = 21.1 Gauss; g = 2.0053.
TABLE 2 Antioxidant Capacity of Cassia roxburghii DC. Leaf Extracts
DPPH assay
β-Carotene
bleaching assay Superoxide assay
Extract Solvent IC50a (mg/L)
Percentage
inhibitionb
± SD
Percentage
inhibitionc
± SD
I EtOH 173.81± 4.94 21.39± 0.58% Inactive
II EtOH 90.19± 2.02 28.50± 3.29% 30.08± 2.49%
III EtOH 18.36± 0.09 33.85± 6.31% 75.00± 1.16%
IV ACN/H2O 88.00± 3.30 34.82± 0.97% 53.03± 0.62%
V ACN/H2O 69.05± 0.74 39.72± 2.77% 59.38± 2.77%
Trolox EtOH 8.36± 0.05 76.35± 0.39% NDd
Vitamin C ACN/H2O 3.81± 0.08 Inactive 100%e
aConcentration required for a 50% decrease in DPPH• absorbance.
b% inhibition of the β-carotene bleaching using a 100 mg/L extract solution.
c% inhibition of the EPR signal intensity of the reference superoxide radical using a 50 mg/L extract
solution.
dNot determined.
e% inhibition of the EPR signal intensity of the reference superoxide radical using a 10 mg/L ascorbic
acid solution.
DISCUSSION
This study allowed identification of two anthraquinones, emodin and
aloe-emodin, and two anthraquinone glycosides, emodin diglucoside and
aloe-emodin diglucoside, besides quercitrin from C. roxburghii leaves, which
TA
B
LE
3
A
n
tib
ac
te
ri
al
an
d
A
n
tif
u
n
ga
l
A
ct
iv
ity
o
f
C
a
ss
ia
ro
xb
u
rg
h
ii
D
C
.
Le
af
E
xt
ra
ct
s
(a
ll
co
n
ce
n
tr
at
io
n
s
ex
p
re
ss
ed
in
μ
g/
m
L)
S.
a
u
re
u
s
P.
a
er
u
gi
n
os
a
E
.
h
ir
a
e
E
.
co
li
A
.
n
ig
er
C
.
a
lb
ic
a
n
s
E
xt
ra
ct
M
IC
a
M
B
C
b
M
IC
M
B
C
M
IC
M
B
C
M
IC
M
B
C
M
IC
M
FC
c
M
IC
M
FC
I
12
5
25
0
62
.5
12
5
12
5
50
0
12
5
50
0
12
5
–
62
.5
12
5
II
12
5
>
50
0
>
50
0
>
50
0
25
0
>
50
0
50
0
>
50
0
50
0
>
50
0
>
50
0
>
50
0
II
I
12
5
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
>
50
0
IV
12
5
50
0
62
.5
25
0
12
5
>
50
0
12
5
50
0
12
5
–
62
.5
12
5
V
12
5
50
0
62
.5
12
5
12
5
>
50
0
12
5
50
0
12
5
–
62
.5
12
5
N
.A
.e
12
5
12
5
>
12
5
>
12
5
6.
25
6.
25
3.
12
5
3.
12
5
–
–
–
–
B
Lf
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
3.
12
5
–
12
5
>
12
5
C
Lg
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
>
12
5
1.
56
2
–
3.
12
5
6.
25
a
M
IC
:
m
in
im
u
m
in
h
ib
ito
ry
co
n
ce
n
tr
at
io
n
(μ
g/
m
L)
.
b
M
B
C
:
m
in
im
u
m
b
ac
te
ri
ci
d
al
co
n
ce
n
tr
at
io
n
(μ
g/
m
L)
.
c
M
FC
:
m
in
im
u
m
fu
n
gi
ci
d
al
co
n
ce
n
tr
at
io
n
(μ
g/
m
L)
.
d
N
A
:
n
al
id
ix
ic
ac
id
.
e B
L:
b
if
o
n
az
o
le
.
f C
L:
cl
o
tr
im
az
o
le
.
TABLE 4 Antiplasmodial Activity and Cytotoxicity of Cassia roxburghii DC. Leaf Extracts
IC50 ± SD (μg/mL) CC50 ± SD (μg/mL)a Selectivity
Extract FcB1 strain MCF-7 index
I 28.5 ± 5.5 31 ± 0 1.1
II 19.5 ± 1.5 44 ± 6 2.26
III 17.25 ± 3 53 ± 6.5 3.1
IV 20 ± 0.5 48.5 ± 6.5 2.43
V 25 ± 2 29 ± 0 1.2
CQ 0.072 ± 0.015 (n = 5) 9.7 134.0
Sodium artesunate 0.0024 ± 0.0012 3.97b 1654.0
aCC50 (μg/mL): drug concentration needed to cause 50% decrease of the cellular viability.
bRef. (18).
have been previously reported in roots and stem bark (19) and in other
Cassia species such as C. fistula, C. nigricans, and C. tora (3, 10).
The redox properties of the five extracts were evaluated with six assays,
two based on UV-visible absorbance measurements and four on radical
species detection by EPR spectroscopy. These different assays were used
to compare the redox molecular content of the extracts by analyzing two
facets of the molecular redox properties: the pro-oxidant and the antioxidant
capacities. Some natural products are pro-oxidant and cannot be antioxidant
(e.g., artemisinin). Other compounds may undergo redox cycles and present
both properties (pro-oxidant and antioxidant) depending on conditions, such
as quinones, pseudo-quinones, and their hydrogen-conjugates (i.e., ascorbic
acid).
Table 1 compares the pro-oxidant capacities of the extracts. None of the
extracts may produce free radicals by direct oxidation in solution as ascorbic
acid does. In the presence of Fe3+ and H2O2, all the extracts generated free
radicals as ascorbic acid does while artemisinin cannot. These results are
in agreement with the presence of quinoid or pseudo-quinoid compounds,
some of which were identified in this study. In the presence of Fe2+, extracts
II–V generate radical species in amounts comparable to those generated by
ascorbic acid and much less than that generated by artemisinin.
Altogether, these results show that the extracts do not contain peroxide-
like molecules and contain pseudo-quinones or quinone-like molecules that
generate free radical species when introduced in a redox cycle. The highest
ascorbic acid-like pro-oxidant activity was observed in extract III. It must be
noted that extract I showed no activity in two pro-oxidant assays.
By examining the results in Table 2, which compares the antioxidant
properties, it appears that extract III is the most active. It demonstrates
the highest activity in the DPPH and superoxide assays. In the β-carotene
bleaching assay, extract V was slightly more active, which, since this assay
discriminates hydrophilic and lipophilic antioxidants, indicates a higher con-
tent of lipophilic redox molecules. Extract I was the least active. Emodin,
aloe-emodin, and quercitrin (the major components of extract I, II, and
III, respectively) have been reported to exhibit free radical scavenging and
antioxidant roles (25, 27). Certainly, these compounds are responsible for the
interesting antioxidant properties of C. roxburghii leaves, but not alone. The
isolated pure compounds showed less antioxidant activity than the tested
extracts in the DPPH assay (unpublished results). Other compounds may
exert synergistic action.
Altogether, the pro-oxidant/antioxidant capacity of the five extracts
shows that extract III has the highest redox molecular content, which can
be related to the antiplasmodial properties. All the tested extracts showed
moderate antiplasmodial activity against a chloroquine-resistant strain of P.
falciparum with IC50 values ranging from 17.25 to 28.5 μg/mL. The ethyl
acetate extract (III) gave the highest antiplasmodial activity. The selectivity
indices were calculated after the evaluation of cytotoxicity on a human breast
cancer cell line. The most selective was ethyl acetate extract.
These results suggest a relationship between the redox capacity and the
antiplasmodial activity of the extracts. The redox properties may be responsi-
ble, at least in part, for the observed antiplasmodial activity of C. roxburghii
leaves. Oxidative stress has been reported to be a key clinical and patho-
biochemical factor as well as an effective therapeutic approach in malaria.
Plasmodium creates a fine balance of redox interactions in parasitized red
blood cells (4). Disruption of this redox equilibrium by Cassia redox active
extracts may be unfavorable for parasite development.
Extracts I, IV, and V possessed antimicrobial activity with MIC values
ranging from 62.5 to 125 μg/mL. Of special interest is the antibacterial activity
against the Gram-negative strain P. aeruginosa, which was more susceptible
to these extracts (MIC = 62.5 μg/mL) than the Gram-positive strains used
in the assay. The extracts exhibited better antifungal properties against C.
albicans than A. niger (Table 3). This antimicrobial activity can support the
traditional use of the plant in skin infections and in wounds.
The antimicrobial activity of C. roxburghii leaf extracts did not correlate
with their redox properties. This may suggest that the redox status is not as
critical for microbial growth as it is for plasmodium.
CONCLUSION
Cassia roxburghii leaf extracts possess interesting redox capacity
(antioxidant and ascorbic acid-like pro-oxidant activities), moderate
antiplasmodial properties, and antimicrobial (antibacterial and antifungal)
effects. A direct relation between the interesting redox power and the
antiplasmodial properties deserves further evaluation of the role of C. rox-
burghii leaf extracts in combating oxidative stress induced pathogenesis.
The antimicrobial properties described do not correlate with these redox
properties, suggesting that redox interactions are not the major factor in the
antimicrobial activity.
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